Table 2.
Characteristics | All Patients (n=136) | Non-CEE (n=76) | CEE (n=60) | P-value |
---|---|---|---|---|
Gender | ||||
Male | 101 (74.3%) | 59 (77.6%) | 42 (70.0%) | 0.312 |
Female | 35 (25.7%) | 17 (22.4%) | 18 (30.0%) | |
Age (year) | 54.169 ± 11.765 | 55.066 ± 10.765 | 53.033 ± 12.926 | 0.319 |
Peritumoral edema | ||||
Negative | 91 (66.9%) | 66 (86.8%) | 25 (41.7%) | 0.000 |
Positive | 45 (33.1%) | 10 (13.2%) | 35 (58.3%) | |
Tumor size | ||||
<2cm | 18 (13.2%) | 16 (21.1%) | 2 (3.3%) | 0.000 |
2-5cm | 95 (69.9%) | 56 (73.7%) | 39 (65.0%) | |
>5cm | 23 (16.9%) | 4 (5.2%) | 19 (32.7%) | |
Location | ||||
Parasinoidal | 37 (27.2%) | 16 (21.1%) | 21 (35.0%) | 0.001 |
Facies convexa | 28 (20.6%) | 16 (21.1%) | 12 (20.0%) | |
Skull base | 24 (17.6%) | 8 (10.5%) | 16 (26.7%) | |
Others | 47 (34.6%) | 36 (47.3%) | 11 (18.3%) | |
Hypertension | ||||
Negative | 113 (83.1%) | 67 (88.2%) | 46 (76.7%) | 0.076 |
Positive | 23 (16.9%) | 9 (11.8%) | 14 (23.3%) | |
Diabetes | ||||
Negative | 132(97.1%) | 74 (97.4%) | 58 (96.7%) | 0.810 |
Positive | 4 (2.9%) | 2 (2.6%) | 2 (3.3%) | |
Epilepsy | ||||
Negative | 134 (98.5%) | 76 (100%) | 58 (96.7%) | 0.109 |
Positive | 2 (1.5%) | 0 (0%) | 2 (3.3%) |
CEE, Cerebral edema exacerbation.
Categorical variables were presented as the number (percentage). Continuous variables consistent with a normal distribution were presented as mean ± standard deviation, otherwise the median and quartile are used. Chi-Square or Fisher Exact tests, as appropriate, were used to compare the differences in categorical variables, while the independent sample t-test was used to compare the differences in continuous variables.